HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luca Baldini Selected Research

ibrutinib

2/2021Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients.
5/2018Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma.
1/2018Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luca Baldini Research Topics

Disease

28Multiple Myeloma
12/2021 - 09/2002
16Lymphoma (Lymphomas)
01/2022 - 07/2004
11Neoplasms (Cancer)
01/2022 - 01/2003
9Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021 - 05/2007
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 09/2009
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2014 - 06/2005
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 07/2005
5Paraproteinemias (Monoclonal Gammopathy)
10/2018 - 04/2005
5Hodgkin Disease (Hodgkin's Disease)
04/2016 - 12/2005
4Infections
10/2021 - 05/2018
4Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2019 - 03/2005
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 06/2005
3COVID-19
02/2022 - 07/2020
3Anemia
02/2021 - 04/2003
3Thrombocytopenia (Thrombopenia)
02/2021 - 05/2018
3Disease Progression
01/2021 - 03/2005
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2018 - 02/2006
3B-Cell Lymphoma (Lymphoma, B Cell)
02/2015 - 04/2003
2Primary Myelofibrosis (Myelosclerosis)
01/2022 - 02/2021
2Plasma Cell Leukemia
09/2021 - 02/2005
2Lymphadenopathy
02/2021 - 11/2019
2Systemic Mastocytosis
02/2021 - 01/2021
2Neutropenia
01/2021 - 01/2020
2Hematologic Neoplasms (Hematological Malignancy)
11/2020 - 12/2018
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2020 - 07/2004
2Splenomegaly
11/2019 - 05/2008
2Osteonecrosis (Kienbock's Disease)
12/2009 - 01/2007
1Dyspnea (Shortness of Breath)
06/2022
1Respiratory Insufficiency (Respiratory Failure)
06/2022
1Eosinophilia
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Hematologic Diseases (Blood Diseases)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2021
1Polycythemia Vera
08/2020

Drug/Important Bio-Agent (IBA)

15Rituximab (Mabthera)FDA Link
01/2021 - 11/2004
12Biological ProductsIBA
12/2021 - 04/2005
10Bortezomib (Velcade)FDA Link
01/2020 - 03/2010
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021 - 02/2009
9Prednisone (Sone)FDA LinkGeneric
01/2020 - 12/2005
6Lenalidomide (CC 5013)FDA Link
01/2021 - 01/2016
6Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 02/2009
6Vinblastine (Vinblastine Sulfate)FDA Link
04/2016 - 12/2005
6Doxorubicin (Adriamycin)FDA LinkGeneric
04/2016 - 12/2005
6Thalidomide (Thalomid)FDA Link
12/2014 - 01/2007
5Biomarkers (Surrogate Marker)IBA
12/2021 - 09/2002
5Bleomycin (Blenoxane)FDA LinkGeneric
04/2016 - 12/2005
5Etoposide (VP 16)FDA LinkGeneric
04/2016 - 12/2005
5Dacarbazine (DIC)FDA LinkGeneric
04/2016 - 12/2005
5Vincristine (Oncovin)FDA LinkGeneric
04/2016 - 12/2005
5fludarabineIBA
04/2013 - 05/2009
4Bendamustine HydrochlorideFDA Link
01/2021 - 09/2013
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 12/2014
4DNA (Deoxyribonucleic Acid)IBA
05/2020 - 02/2005
4Lomustine (CCNU)FDA Link
04/2016 - 12/2005
4Procarbazine (Matulane)FDA Link
04/2016 - 12/2005
4Vindesine (Vindesin)IBA
04/2016 - 12/2005
4AnthracyclinesIBA
03/2010 - 03/2006
3venetoclaxIBA
11/2022 - 09/2021
3ibrutinibIBA
02/2021 - 01/2018
3SteroidsIBA
01/2020 - 07/2004
3Immunoglobulin M (IgM)IBA
11/2019 - 03/2005
2Monoclonal AntibodiesIBA
01/2022 - 11/2020
2Immunoglobulin G (IgG)IBA
01/2022 - 07/2009
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2021 - 04/2003
2Immunoglobulin A (IgA)IBA
02/2021 - 07/2009
2Circulating Tumor DNAIBA
08/2020 - 01/2018
2Antiviral Agents (Antivirals)IBA
01/2020 - 04/2019
2MicroRNAs (MicroRNA)IBA
08/2014 - 05/2011
2Epirubicin (Ellence)FDA LinkGeneric
04/2012 - 04/2003
2Mechlorethamine (Nitrogen Mustard)FDA Link
11/2011 - 12/2005
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
12/2010 - 02/2005
2AntigensIBA
10/2010 - 04/2005
2Diphosphonates (Bisphosphonates)IBA
12/2009 - 01/2007
1Oxygen (Dioxygen)IBA
06/2022
1ruxolitinibIBA
01/2022
1Pharmaceutical PreparationsIBA
12/2021
1ElementsIBA
10/2021
1midostaurinIBA
02/2021
1OMS 2017IBA
02/2021
1Proteasome InhibitorsIBA
01/2021
1pomalidomideIBA
01/2021
1daratumumabIBA
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2021
1Reticulin (Reticular Fiber)IBA
01/2021
1Tryptases (Tryptase)IBA
01/2021
1ChromatinIBA
11/2020

Therapy/Procedure

19Therapeutics
06/2022 - 12/2005
11Drug Therapy (Chemotherapy)
01/2019 - 11/2004
6Radiotherapy
04/2014 - 12/2005
4Immunotherapy
12/2021 - 04/2005
4Stem Cell Transplantation
11/2021 - 12/2010
4Salvage Therapy
09/2013 - 05/2007
2Aftercare (After-Treatment)
04/2016 - 06/2005
2Autologous Transplantation
12/2014 - 06/2005
1Cannula
06/2022
1Artificial Respiration (Mechanical Ventilation)
02/2022
1Cell Transplantation
01/2022
1Hematopoietic Stem Cell Mobilization
11/2021